You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Primary familial polycythemia due to EPO receptor mutation, look for clinical trials, and connect with others living with it — all in one place.
Open the full Primary familial polycythemia due to EPO receptor mutation hub →Primary familial polycythemia due to EPO receptor mutation is a rare condition. Also known as Primary hereditary and congenital polycythemia, Primary familial and congenital erythrocytosis due to erythropoietin receptor mutation, PFCE, PFCP, Primary hereditary and congenital erythrocytosis, Primary familial and congenital polycythemia, Primary hereditary and congenital erythrocytosis due to erythropoietin receptor mutation, Primary familial and congenital polycythemia due to erythropoietin receptor mutation. Tomeko brings together the specialists, research, clinical trials, treatments and community for Primary familial polycythemia due to EPO receptor mutation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:90042 · OMIM 133100 · ICD-10 D75.0 · GARD 0009843
Start by learning the basics from an authoritative source, find a specialist or center that sees Primary familial polycythemia due to EPO receptor mutation, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Primary familial polycythemia due to EPO receptor mutation, filtered to your area.
Tomeko shows live, recruiting studies for Primary familial polycythemia due to EPO receptor mutation from ClinicalTrials.gov on the hub.